Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05049460 · ClinicalTrials.gov registry record · NA
Adjunctive Transcranial Stimulation to Reduce Impulsivity in Opiate Use Disorder
A NA study, sponsored by Gopalkumar Rakesh.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT05049460 is a NA study that has completed, run by Gopalkumar Rakesh. The registered enrollment target is 23 participants.
The verdict
NCT05049460, a NA study, has completed, sponsored by Gopalkumar Rakesh.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The goal of this study is to examine the effect of four sessions of theta burst stimulation (TBS) versus sham TMS on attentional bias for smoking and opioid cues versus neutral stimuli in a population of patients with tobacco use disorder (TUD) with comorbid opioid use disorder (OUD) that is stable and on treatment with buprenorphine. The investigators will also examine the effect of TBS on craving for cigarettes as well as opioids. Participants will perform a stress induction procedure that mirrors an optimum combination of cues that trigger tonic craving in their environment while exposed to stress. All four sessions of TBS/sham TMS will be performed on the same day, with each session lasting for approximately 10 minutes and separated by 50 minute intervals.
Interventions
- DEVICE Sham TMS
- DEVICE Theta Burst Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05049460
The ClinicalTrials.gov registry entry for NCT05049460 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gopalkumar Rakesh, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham TMS is the first listed.
NCT05049460 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05049460 about?
NCT05049460 is a clinical study titled "Adjunctive Transcranial Stimulation to Reduce Impulsivity in Opiate Use Disorder". The goal of this study is to examine the effect of four sessions of theta burst stimulation (TBS) versus sham TMS on attentional bias for smoking and opioid cues versus neutral stimuli in a population of patients with tobacco use disorder (TUD) with comorbid opioid use disorder (OUD) that is stable ...
What is the current status of trial NCT05049460?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2021-09-15. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT05049460?
The interventions under investigation include: Sham TMS (DEVICE), Theta Burst Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05049460?
This trial is sponsored by Gopalkumar Rakesh, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.